Long-term survival with donor CD19 CAR-T cell treatment for relapsed patients after allogeneic hematopietic stem cell transplantation.
Zhang C, Wang X, Yi H, Wang Y, Yan Z, Zhou J, Yang T, Liang A, Wang Z, Ma Y, Wen Q, Gao L, Gao L, Kong P, Tan X, Jiang E, Zhang X.
Zhang C, et al. Among authors: wen q.
J Hematol Oncol. 2024 Oct 29;17(1):103. doi: 10.1186/s13045-024-01626-6.
J Hematol Oncol. 2024.
PMID: 39468581
Free PMC article.